Skip to NavigationSkip to content


The biggest side-effect of making medicine

Published on 16/09/15 at 11:02am
Pharma needs to ensure access to medicines without damaging R&D
clinical trial

International intellectual property regulations are doing serious damage to the pharmaceutical industry and, by extension, to the health of people around the world.

The core of the problem: growing global concern about how to ensure affordable access to medicine without damaging the initiatives that sustain pharmaceutical research. Attempts to address the issues have resulted in significant disagreement between developed and emerging economies about just how much protection should be available to companies that develop new drugs.

Global Generics Strategy Summity

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches